Medican Enterprises Stock Current Asset
Medican Enterprises fundamentals help investors to digest information that contributes to Medican Enterprises' financial success or failures. It also enables traders to predict the movement of Medican Pink Sheet. The fundamental analysis module provides a way to measure Medican Enterprises' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medican Enterprises pink sheet.
Medican |
Medican Enterprises Company Current Asset Analysis
Medican Enterprises' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Medican Enterprises Current Asset | 74 K |
Most of Medican Enterprises' fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medican Enterprises is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Medican Enterprises has a Current Asset of 74 K. This is 99.99% lower than that of the Pharmaceuticals sector and 99.99% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Medican Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medican Enterprises' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medican Enterprises could also be used in its relative valuation, which is a method of valuing Medican Enterprises by comparing valuation metrics of similar companies.Medican Enterprises is currently under evaluation in current asset category among its peers.
Medican Fundamentals
| Return On Asset | -68.18 | |||
| Current Valuation | 7.77 M | |||
| Shares Outstanding | 134.8 M | |||
| Shares Owned By Institutions | 0.52 % | |||
| Price To Sales | 2.72 X | |||
| Net Income | (56.52 M) | |||
| Cash And Equivalents | 9.4 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.98 M) | |||
| Earnings Per Share | (17.92) X | |||
| Beta | 104.43 | |||
| Market Capitalization | 13.48 K | |||
| Total Asset | 112.62 K | |||
| Retained Earnings | (166.24 M) | |||
| Working Capital | (9.66 M) | |||
| Current Asset | 74 K | |||
| Current Liabilities | 9.74 M | |||
| Net Asset | 112.62 K |
About Medican Enterprises Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medican Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medican Enterprises using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medican Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Medican Enterprises
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medican Enterprises position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medican Enterprises will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Medican Enterprises could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medican Enterprises when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medican Enterprises - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medican Enterprises to buy it.
The correlation of Medican Enterprises is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medican Enterprises moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medican Enterprises moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medican Enterprises can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Medican Pink Sheet
Medican Enterprises financial ratios help investors to determine whether Medican Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medican with respect to the benefits of owning Medican Enterprises security.